Evaluation of gait kinematics and kinetics using a powered ankle-foot orthosis for gait assistance in people with multiple sclerosis by Petrucci, Matthew N.
  
 
 
 
 
 
 
 
 
 
 
© 2016 Matthew Nugent Petrucci 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
EVALUATION OF GAIT KINEMATICS AND KINETICS USING A POWERED ANKLE-FOOT ORTHOSIS 
FOR GAIT ASSISTANCE IN PEOPLE WITH MULTIPLE SCLEROSIS 
 
 
 
 
 
BY 
 
MATTHEW NUGENT PETRUCCI 
 
 
 
 
 
 
 
THESIS 
 
Submitted in partial fulfillment of the requirements 
for the degree of Master of Science in Mechanical Engineering 
in the Graduate College of the 
University of Illinois Urbana-Champaign, 2016  
 
 
 
 
Urbana, Illinois 
 
 
  Adviser: 
    
   Professor Elizabeth Hsiao-Wecksler
 ii 
 
ABSTRACT 
Gait impairment is one of the many motor symptoms of multiple sclerosis (MS) but has the 
largest perceived impact on overall quality of life for people with the disease. Currently, there is 
no cure for MS and no treatments or therapies can reverse the progression of symptoms. 
Typically, gait speed becomes slower with disease progression requiring the prescription of 
assistive devices to maintain or improve movement ability and promote independence. For 
people with MS who suffer from drop foot (i.e., the diminished or lack of ability to dorsiflex the 
foot), prescription of a passive ankle-foot orthosis is common. The purpose of these devices is 
to hold the foot in neutral position and prevent the foot from dropping during forward swing. 
Although these devices can be beneficial, ankle-foot orthoses generally prevent the ability to 
plantarflex the ankle, and successful implementation of these devices has been limited. 
Recently, powered orthotics and exoskeletons have been developed for people with 
neurological impairments or injuries that impact gait function. These devices can provide active 
motion control and assistance in both plantarflexion and dorsiflexion of the ankle. The purpose 
of this thesis was to investigate the utility of a powered ankle-foot orthosis for gait assistance in 
people with MS. Specifically, the analyses performed in this thesis focused on the kinematic and 
kinetic changes in gait associated with a powered ankle-foot orthosis compared to a passive 
ankle-foot orthosis and walking without an assistive device. Results indicate that the vertical 
ground reaction force during the propulsive phase of gait (i.e., terminal stance) was increased 
with the powered ankle-foot orthosis, counteracting the diminished behavior typically observed 
in people with MS. However, peak plantarflexor torque during this same phase of gait was 
diminished compared to walking without an assistive device, which may have been due to a 
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slower gait speed. The only difference between a powered ankle-foot orthosis or prescribed 
passive ankle-foot orthosis was an increased mid-stance minima in the vertical ground reaction 
force, which could also be an indicator of slower gait speed. The findings of this study provide 
an initial baseline for future studies of powered orthoses in people with MS. Further 
investigation and tuning of the powered orthosis used in this study is needed.  
  
 iv 
 
 
 
 
 
 
 
 
 
 
 
 
To Family 
  
 v 
 
ACKNOWLEDGMENTS 
So many people have helped me get to where I am today and thanking all of them would be 
impossible in just a few paragraphs. First, I would like to thank my adviser, Elizabeth Hsiao-
Wecksler, for giving me the opportunity to work in her lab and do some very exciting research. 
Her guidance and willingness to explore new avenues of research enabled this project as well as 
others in my graduate career. I would like to thank all members of the Human Dynamics and 
Controls Lab, former and present, for their support and help along the way as well. In 
particular, Morgan Boes, for her involvement in the collection and analysis of data for this 
project. Also, I need to thank the many undergrads that helped with data analysis, including 
Patrick Wong, Jacob Haynie, and Emily Matijevich. All of them have bright futures in front of 
them and they will be outstanding scientist. Outside of our lab, I would like to thank members 
of the Exercise Neuroscience Research Laboratory, including the director Rob Motl, postdoc 
Yvonne Learmonth, and graduate student Rachel Klaren. Without their collaboration, this 
project would have simply not happened. 
 
The most important people in my life are my family. To my Mom and Dad, for their unwavering 
support of my wild-eyed dreams along the way. They always made me feel like I could follow 
my dreams, and reinforced that hard work, determination, and being a good person to others 
are key values to success. Of course, no youngest child can get very far without their older 
siblings. To my sister, Angie, for always supporting me and her inspiration. I always wanted to 
grow up and live in Chicago just like her. I almost did, just landed a few hours South. To my big 
brother, Tony, who always has my back and for his inspiration as well. His diligence, hard work, 
 vi 
 
and willingness to help others is admirable. I have always tried to be as awesome as my older 
siblings, and I hope that I came close. Love you all! 
 
Thank you to my extended family and friends, including my Mother and Father-in-law, Lyndalou 
and Bryan. They have also always supported me for what I wanted to do. My Father-in-law is 
the ultimate sacred clown, or heyoka. Look it up if you have a chance. To my Brother-in-law, 
Dominyck, I hope that you continue to follow your dreams in sports and in life.  
 
Last, but certainly not least, I would like to thank my intelligent, caring, and amazing wife 
Samantha. Her abilities as a scientist constantly drive me to be better at what I do. There are 
few people as intelligent as her. Beyond her scientific guidance, her unwavering love and 
support mean the absolute world to me, and I honestly don’t think I could have done this 
without her. This is the first chapter, of many, in our lives together and I am excited for what 
lies ahead.  
 
  
 vii 
 
TABLE OF CONTENTS 
Table of Figures ............................................................................................................................. viii 
Table of Tables ................................................................................................................................ ix 
1 Literature Review .................................................................................................................... 1 
1.1 Walking Gait Analysis ....................................................................................................... 1 
1.2 Multiple Sclerosis ............................................................................................................. 3 
1.3 Treatments and Rehabilitation for MS Gait Impairments ............................................... 5 
1.4 Powered Orthoses ............................................................................................................ 8 
1.5 Goals of Thesis ................................................................................................................ 10 
2 Comparison of Gait Kinematics and Kinetics between a Passive and Powered Ankle-Foot 
Orthoses in People with Multiple Sclerosis .................................................................................. 12 
2.1 Abstract .......................................................................................................................... 12 
2.2 Introduction.................................................................................................................... 13 
2.3 Methods ......................................................................................................................... 16 
2.3.1 Participants ............................................................................................................. 16 
2.3.2 Portable Powered Ankle Foot Orthosis .................................................................. 16 
2.3.3 Protocol for PPAFO Training and 6-Minute Walk Tests .......................................... 17 
2.3.4 Protocol for Current Study ...................................................................................... 18 
2.3.5 Data Analysis ........................................................................................................... 19 
2.3.6 Reasons for Participant Exclusion in Current Analysis ............................................ 21 
2.3.7 Statistical Analysis ................................................................................................... 21 
2.4 Results ............................................................................................................................ 22 
2.5 Discussion ....................................................................................................................... 23 
2.6 Conclusions..................................................................................................................... 27 
3 Conclusions and Future Work ............................................................................................... 37 
3.1 Future Work ................................................................................................................... 37 
4 References ............................................................................................................................. 40 
Appendix A: Additional Ankle Angle Data..................................................................................... 48 
Appendix B: Analysis of Changing PPAFO Weight on Ankle Torque ............................................. 55 
 
  
 viii 
 
TABLE OF FIGURES 
Figure 1: The portable powered ankle-foot orthosis (PPAFO). .................................................... 11 
Figure 2: The portable powered ankle-foot orthosis (PPAFO). Photo is courtesy of Professor   
Cliff Shin in the Department of Industrial Design at the University of Illinois at Urbana-
Champaign. ....................................................................................................................... 28 
Figure 3: PPAFO actuation timings and magnitudes during the gait cycle (Perry 1992). ............. 29 
Figure 4: Data collection configuration of force plates with in the elevated walkway. The  
motion capture space is outlined in the blue dotted line. ............................................... 30 
Figure 5: Data analysis parameters for ground reaction forces, ankle angle, and ankle torque. 
The vertical dashed line in each plot indicates the time of toe-off. ................................. 31 
Figure 6: Average ground reaction force and torque parameters (± SEM) where significant 
differences were found between footwear conditions. The horizontal bar indicates a 
significant difference between conditions (p < 0.05). ...................................................... 32 
Figure 7: Average behaviors of ground reaction forces and ankle torque across conditions.     
The data are displayed as average ± standard deviation in the right panels. .................. 33 
Figure 8: All ankle angle trials by condition for participant 005. Note, even though there are 
data missing in the middle of the PPAFO trial, all of the parameters were able to be 
identified. .......................................................................................................................... 49 
Figure 9: All ankle angle trials by condition for participant 012. Note there are not enough    
data in the AFO and PPAFO conditions to be able to identify every ankle angle 
parameter. Thus, this participant was not included in the statistical analysis. ............... 50 
Figure 10: All ankle angle trials by condition for participant 013. Note, although there is 
continuous data during swing of the PPAFO trial, it was determined that the small 
“jump” in the data around 86% gait cycle was caused by motion markers dropping in 
and out of the frame. Thus, we could not include the max dorsiflexion angle during 
swing in the statistical analysis. ........................................................................................ 51 
Figure 11: All ankle angle trials by condition for participant 018. Note, there were more than 
three trials in the AFO condition. Only the first three were included in the analysis. ..... 52 
Figure 12: All ankle angle trials by condition for participant 018. Note, there were more than 
three trials in the SHOES and AFO conditions. Only the first three were included in the 
analysis. ............................................................................................................................. 53 
Figure 13: Average ankle angle behaviors across footwear conditions for all five participants 
(top) and the three participants (bottom) that did not have parameters lost due to 
marker dropout. Data are displayed as the average ± SD. ............................................... 54 
 
  
 ix 
 
TABLE OF TABLES 
Table 1: Demographics of all participants with reasons for exclusion from the overall analysis 
(assistive device required or no "clean" heel strikes) or ankle angle analysis (did not  
have a trial with all ankle angle parameters) highlighted. ............................................... 34 
Table 2: Average ground reaction force, ankle torque, and gait speed parameters across 
footwear conditions (± SD) with p-values from the univariate ANOVAs. Significant p-
values are in bold (p < 0.05). ............................................................................................. 35 
Table 3: Average ankle angle of 3 participants that did not have missing motion data across 
footwear conditions (+/- SD). No main effect of the MANOVA for these parameters     
was found, so no univariate p-values are provided. ........................................................ 36 
Table 4: Weight of each component of the PPAFO. ..................................................................... 55 
Table 5: Differences in peak plantarflexor torque at specific increments of additional foot 
weight. .............................................................................................................................. 56 
 1 
 
1 Literature Review 
1.1 Walking Gait Analysis 
Through years of development, humans acquire a specific method of walking, or gait. The 
purpose of gait is to move the body forward through a repetitive pattern of lower limb 
movements (Perry 1992). The basic tasks of a person’s gait are to maintain support of the upper 
body during stance, prevent falling, and allow for safe clearance of the swing limb as it comes 
forward (Winter 1989). The central nervous system coordinates muscle activations to control 
the forces (kinetics) generated by the lower limbs to achieve the desired motion (kinematics) 
(Winter 1984). A gait cycle is defined as starting with the heel strike of one leg and ending with 
the next heel strike of the same leg. The walking gait cycle for an adult human can be divided 
into two phases, stance and swing. Stance is approximately the first 60% of the gait cycle when 
the foot is on the ground and swing is when the foot is off the ground for the last ~40%. These 
phases are typically divided into sub-phases and events that have functional significance (Perry 
1992).  
Initial Contact (~0-2% of the gait cycle): Heel strike of the lead (ipsilateral) limb occurs 
while the trailing (contralateral) limb is still in contact with the ground.  
Loading Response (~2-10% of the gait cycle): The contralateral limb propels the weight 
of the body towards the ipsilateral limb. During this sub-phase, the ground reaction 
forces (GRFs) in the vertical and anterior-posterior directions steadily increase under the 
ipsilateral limb, and the ankle generates a dorsiflexor torque as the foot comes in 
contact with the ground (Winter 1984).  
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Mid-Stance (~10-30% of the gait cycle): The ipsilateral limb fully supports the weight of 
body while the contralateral limb begins to swing forward for the next step. The kinetics 
associated with this phase of gait are a slight decrease in the vertical GRFs while the 
anterior-posterior GRFs approach zero under the ipsilateral limb. Additionally, the ankle 
joint steadily progresses into dorsiflexion with an increasing plantarflexor torque being 
generated (Winter 1984).   
Terminal Stance (~30-50% of the gait cycle): After mid-stance, the weight of the body 
moves in front of the ipsilateral limb as it becomes necessary to propel the body 
towards the contralateral limb. This is accomplished through an increase in vertical and 
anterior-posterior GRFs and plantarflexor torque at the ankle of the stance (ipsilateral) 
limb. At this point, the GRFs generated by the body are propulsive to drive the body 
forward (Winter 1984). 
Pre-Swing (~50%-60% of the gait cycle): The contralateral limb comes in contact with 
the ground as the ipsilateral limb propels the weight of the body towards the 
contralateral limb. During this sub-phase, the body is in double support again with both 
legs on the ground. At the end of pre-swing, the stance leg comes of the ground and the 
contralateral limb accepts the weight of the body.  
Initial Swing (~60%-73% of the gait cycle): This phase is the beginning of swing for the 
ipsilateral limb. No ground reaction forces are present for the ipsilateral limb because it 
is not in contact with the ground. The ankle joint of the ipsilateral limb generates a 
dorsiflexor torque to prevent the toes from contacting the ground (Winter 1984).  
 3 
 
Mid-Swing (~73%-87% of the gait cycle):  The ipsilateral limb moves from being in line 
with the contralateral limb to slightly ahead of it at the end of this sub-phase. A 
dorsiflexor torque on the ankle of the ipsilateral limb continues to be generated to 
ensure toe clearance (Winter 1984). 
Terminal Swing (~87%-100% of the gait cycle): The ipsilateral limb moves into position 
for contact with the ground. A dorsiflexor torque is still being generated to prevent the 
foot from slapping down during heel strike (Winter 1984). The sub-phase ends with heel 
strike of the ipsilateral limb.  
Using the tools of biomechanics to measure the kinetics and kinematics of the lower limbs, it is 
possible to address the potential changes and underlying neural control of movement. This 
information provides insight into possibilities for interventions and rehabilitation for gait 
disorders to improve overall gait function. 
 
1.2 Multiple Sclerosis 
Multiple sclerosis (MS) is a neurodegenerative disease that affects 250,000 to 350,000 people 
in the United States (Anderson et al. 1992; Noseworthy et al. 2000). Symptoms of MS are 
caused by a death of white matter in the central nervous system. White matter cells, or 
oligodendrocytes, provide insulation to neurons for proper signal transduction. The central 
nervous system malfunctions with lesions of white matter leading to several impairments 
including the motor symptoms of spasticity, decreased postural control, fatigue, and abnormal 
gait (Freal et al. 1984; Noseworthy et al. 2000; Sosnoff et al. 2011; Motl 2013). The primary 
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cause of MS is not fully understood and no cure exists. The different types of disease course are 
not fully defined (Confavreux and Vukusic 2006), but the majority of people with MS start in 
what is considered relapsing-remitting multiple sclerosis (RRMS) (Noseworthy et al. 2000; 
Confavreux and Vukusic 2006). In RRMS, the symptoms can present over a periods of days, and 
then revert back to normal spontaneously (Noseworthy et al. 2000). A smaller portion of people 
with MS start in a more progressive state known as primary-progressive multiple sclerosis 
(PPMS) where symptoms gradually increase without relapses (Noseworthy et al. 2000; 
Confavreux and Vukusic 2006). As the relapses become more frequent and the increase in 
disease severity becomes more constant, people with RRMS can convert to secondary-
progressive multiple sclerosis (SPMS). People with PPMS can also convert to progressive-
relapsing multiple sclerosis (PRMS), where the constant progression of the disease is 
accompanied by relapses (Confavreux and Vukusic 2006). Ultimately, symptoms become more 
severe and mobility is increasingly limited with disease progression, resulting in decreased 
quality of life.  
 
Out of all of the symptoms of MS, trouble with walking becomes more common and 
devastating as the disease progresses. People with MS perceive that decreases in walking ability 
has the largest impact on overall quality of life compared to other symptoms (Larocca 2011). 
Furthermore, people with MS perceive that walking is the most valuable function, followed by 
visual function and cognition (Heesen et al. 2008). Changes in gait associated with MS include 
slower steps that are shorter and wider compared to controls (Benedetti et al. 1999; Sosnoff et 
al. 2012). Furthermore, muscle activation can become uncoordinated in the plantarflexors and 
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dorsiflexors of the lower leg (Benedetti et al. 1999). In terms of gait kinematics, people with MS 
exhibit reduced hip extension, knee extension, and ankle plantarflexion. These changes are 
accompanied by a decreased ability to generate propulsive forces and plantarflexor torque 
during terminal stance compared to healthy controls (Benedetti et al. 1999; Kelleher et al. 
2010). Other symptoms, such as fatigue, spasticity, and cognitive impairment, can influence gait 
impairments and increase variability of gait parameters (Benedict et al. 2011; Sehle et al. 2011; 
Wurdeman et al. 2011; Sosnoff et al. 2012). Fatigue also leads to significantly shorter six-minute 
walk test (6MW) distances, a metric typically used to measure endurance (Goldman et al. 
2008). The mechanisms behind these changes in gait are not fully understood. Nonetheless, it 
has been proposed that changes in gait associated with MS lead to decreased motor activity, 
leading to overall deconditioning, and increased motor disability (Motl et al. 2010).  
 
1.3 Treatments and Rehabilitation for MS Gait Impairments 
Similar to other neuromuscular disorders, the most common treatment for gait impairments in 
people with MS is the prescription of some type of assistive device (i.e., ankle-foot orthoses, 
canes, walkers, or wheelchairs) in order to maintain mobility and quality of life. Wheelchairs 
become increasingly necessary as gait and balance symptoms become more severe (Fay and 
Boninger 2002) and are the most commonly prescribed assistive device (Finlayson et al. 2001). 
Although helpful, there is a lack of evidence to support the prescriptions made of assistive 
devices for people with MS based on their mobility status (Souza et al. 2010). Furthermore, if 
the user does not perceive that the device is helping or if it is not meeting their needs, they can 
often be abandoned (Verza et al. 2006; Souza et al. 2010). Consequently, gait interventions and 
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treatments are needed for people with MS that are perceived to be helpful and can improve 
mobility before it deteriorates. 
 
Before a wheelchair is needed, passive ankle foot orthoses (AFOs) are prescribed for lower limb 
weakness or foot drop in MS. Usually consisting of a carbon fiber or plastic material, the main 
purpose of AFOs is to provide stability at the ankle joint while also providing more normative 
biomechanics during the swing phase of gait (Souza et al. 2010). Positive results for balance and 
posture (Cattaneo et al. 2002) as well as gait have been demonstrated with these passive 
devices. Specifically, improved gait speed, increased dorsiflexion during swing, and decreased 
metabolic cost have been achieved (Bregman et al. 2010). However, the positive results were 
only observed in a subset of their population who did not attain neutral ankle angle during 
swing. For the rest of the participants in that study, the AFO did not provide any further benefit 
to these parameters because they were less impaired. An energy storing AFO with a spring-like 
behavior to assist with ankle push-off was able to decrease metabolic cost by 9.8%, and 
increase the peak plantarflexor torque in patients with MS (Bregman et al. 2012). Work at the 
ankle also decreased with the AFO, but a shift towards more work produced at the hip was 
observed. Null results for improving gait endurance (e.g., timed 25 foot walk test) have also 
been observed with AFOs (Sheffler et al. 2008). Therefore, the results of passive AFOs for 
mitigating gait impairment of MS have been mixed and limited to specific conditions and 
populations.  
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Amongst the treatments for MS gait impairments under development, pharmacological agents 
and exercise have been demonstrated to improve gait and MS symptoms. Pharmacologically, 
many drugs have been developed to try and target the mechanisms of MS specifically and 
reduce the amount of lesions in the brain (Khan et al. 2008). Treatments are able to temporarily 
reduce disease severity, but no drug has been able to reverse the disease course. Extended-
release dalfampridine, a pharmacological agent that improves signal transduction in 
demyelinated neurons, has been developed to improve ambulation. Results of the clinical trials 
suggest that gait speed can be improved with the drug as well as other symptoms (i.e., 
spasticity and strength) (Hersh and Rae-Grant 2012). In addition to pharmacological agents, 
exercise can provide modest improvement in walking endurance, speed, metabolic cost, and 
potentially mitigate MS severity (Motl et al. 2010). Furthermore, exercise can increase strength 
and boost other physiological functions, including anti-inflammatory agents within the body 
(Motl and Pilutti 2012; Motl and Sandroff 2015). Although not curative, exercise and 
pharmacological agents provide promising options for increasing mobility and mitigating MS 
symptoms.  
 
Different forms of physical therapy are an option for gait rehabilitation, especially for patients 
with severe levels of MS (Expanded Disability Severity Scale (EDSS) ≥ 6.0). Traditional forms of 
physical therapy (i.e., passive or active movement facilitation by a physical therapist, task-
dependent training) can improve gait measures and gait speed (Lord et al. 1998; Wiles et al. 
2001). Several studies have shown that using body weight support treadmill training can 
improve gait (Pilutti et al. 2011) along with muscle strength and spasticity (Giesser et al. 2007). 
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Body weight support treadmill training requires a physical therapist to physically assist the 
person’s legs while they walk on the treadmill. The training can focus on different components 
of the walking motion, such as weight acceptance or transfer during the gait cycle. Robotic 
treadmill training, where this process of repetitive external assistance is provided by a robotic 
device that attaches to the lower limbs, can induce a similar improvement in gait function as 
body weight support treadmill training (Lo and Triche 2008) and traditional physical therapy 
gait training (Schwartz et al. 2012). However, one possible limitation of both robotic and 
conventional training is the lack of long term positive effects on gait function if the training is 
stopped (Beer et al. 2008). Furthermore, both types of training are limited to the lab or clinic 
setting and cannot be used in the changing environments of everyday life. Overall, these 
studies demonstrate that physical therapy can induce improvements in gait function in people 
with MS; however, these types of training are limited to the lab or clinic setting, and more 
needs to be understood about how to induce long term positive effects in gait for people with 
MS. 
 
1.4 Powered Orthoses  
Powered exoskeletons and orthoses are part of a burgeoning field focused on developing daily 
wear and rehabilitative robotic devices to provide assistance to joints of the lower limbs. For 
people who are ambulatory with gait impairments, powered orthoses for the knee (Nikitczuk et 
al. 2007), ankle (Blaya and Herr 2004; Ferris et al. 2005; Ferris et al. 2006; Roy et al. 2009; 
Shorter et al. 2011a; Mooney et al. 2014; Neubauer et al. 2014), or both the knee and ankle 
simultaneously (Sawicki and Ferris 2009) have been developed. Using active motion control, 
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powered orthoses can increase propulsive torque during late stance (Ferris et al. 2005), and 
decrease the metabolic cost of walking (Mooney et al. 2014) in healthy individuals. Recent 
studies have demonstrated that powered AFOs can encourage more normative biomechanics in 
people with gait impairments. Pilot data from post-stroke patients demonstrated an increase in 
peak plantarflexor torque of 16% while walking on a treadmill (Takahashi et al. 2015) and 
improved motor control and movement smoothness after seated rehabilitation of ankle joint 
movement (Roy et al. 2009). Additionally, a variable–impedance AFO was able to prevent foot 
slap during loading response for people with foot drop (Blaya and Herr 2004). Overall, powered 
orthotics have the capability of providing active motion control and assistance during the gait 
cycle that can help overcome gait impairments.  
 
A portable powered ankle-foot orthosis (PPAFO) test bed has been developed to investigate the 
application of powered devices for the ankle-foot complex in gait disorders (Figure 1). The 
PPAFO is powered by a bidirectional pneumatic rotary actuator that is capable of providing 
both dorsiflexor and plantarflexor torque during the gait cycle (Shorter et al. 2011a). On board 
electronics control the flow of compressed CO2 by way of two solenoid values. Sensors on the 
device inform different control schemes that determine the correct timing of actuation based 
on the current gait state (0-100% gait cycle) of the user (Li et al. 2011; Shorter et al. 2011a; 
Islam et al. 2016; Islam and Hsiao Wecksler 2016). The PPAFO is also able to control gait in 
multiple environments, including ascending and descending stairs or ramps (Li and Hsiao-
Wecksler 2013). Pilot studies with the device have demonstrated improved propulsive ground 
reaction forces during terminal stance for cauda equina syndrome, a neurological condition 
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where the person is unable to generate plantarflexor torque at the ankle (Shorter et al. 2011b). 
Thus, the PPAFO is a capable testbed for investigating the utility of a powered ankle foot 
orthosis for improving gait kinematics and kinetics in people with MS.  
 
1.5 Goals of Thesis 
As part of a larger study focused on the application of a powered ankle-foot orthosis in people 
with MS across multiple disability levels (Boes et al. 2015), the goal of this thesis was to 
investigate the potential changes in kinematics and kinetics of gait using the PPAFO compared 
to walking with a prescribed orthosis and shoes. Chapter 2 contains the main experimental 
study. Chapter 3 covers general conclusions of the study and possible future directions for this 
research. Two appendices were included: the first contains all of the ankle angle data for the 
participants (Appendix A); the second contains the description and results of a small study 
regarding whether to include the PPAFO weight in ankle torque calculations (Appendix B). 
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Figure 1: The portable powered ankle-foot orthosis (PPAFO). 
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2 Comparison of Gait Kinematics and Kinetics between a Passive and Powered Ankle-Foot 
Orthoses in People with Multiple Sclerosis 
2.1 Abstract 
Prescription of a passive ankle-foot orthosis is common for gait impairment in people with 
multiple sclerosis (MS); however, successful implementation has been limited. Furthermore, 
they can often be abandoned by the user if they are not perceived to be helpful. In the current 
study, we used a portable powered ankle-foot orthosis (PPAFO) testbed to evaluate the utility 
of powered ankle orthoses for improving gait biomechanics in people with MS. Five participants 
from a larger study focused on the efficacy of the PPAFO in people with MS performed short 
walking trials on a walkway with embedded force plates in three footwear conditions: (1) 
normal walking shoes [SHOES], (2) their prescribed AFO [AFO], and (3) the PPAFO [PPAFO]. 
Assistive devices were worn on the more impaired limb. Twenty-seven relevant kinetic and 
kinematic parameters (ground reaction force, ankle torque and angle) were analyzed for the 
more impaired limb. The propulsive vertical ground reaction force was found to increase with 
the PPAFO compared to the SHOES condition (p=0.026). Several significant changes (i.e., 
increased mid-stance minima of vertical ground reaction forces compared to the AFO condition 
(p=0.048) and decreased peak plantarflexor torque compared to the SHOES condition 
(p=0.008)) were consistent with the slower gait speed in the PPAFO condition. No significant 
changes were observed in the kinematic parameters. Overall, these results suggest that the 
PPAFO could be used to modify gait kinetics in people with MS. However, further investigation 
into increasing gait speed and the corresponding kinetics, possibly through changes in device 
control and extended training time with PPAFO, is needed.  
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2.2 Introduction 
Multiple sclerosis (MS) is a neurodegenerative disease that causes several motor symptoms 
that become more severe as the disease progresses. Symptoms include spasticity, decreased 
postural control, fatigue, and abnormal gait (Freal et al. 1984; Noseworthy et al. 2000; Sosnoff 
et al. 2011; Motl 2013). People with MS perceive that decreases in walking ability have the 
largest impact on overall quality of life compared to other symptoms (Larocca 2011). Typically, 
gait speed is slower (Benedetti et al. 1999; Kelleher et al. 2010; Sosnoff et al. 2012) and early 
fatigue is common (Sehle et al. 2011; McLoughlin et al. 2015). Changes in biomechanics that are 
evident with increasing disease severity include decreases in ankle plantarflexion, hip 
extension, knee extension, plantarflexor torque, braking ground reaction forces during loading 
response, and propulsive ground reaction forces during terminal stance (Benedetti et al. 1999; 
Kelleher et al. 2010). Interventions or therapies that are able to target these changes in 
biomechanics could improve gait of people with MS.  
 
The prescription of ankle foot orthoses (AFOs) for gait impairments of people with MS has had 
limited success. Use of passive and semi-active AFOs can improve standing balance, but also 
impair tasks such as rising from a chair or walking (Cattaneo et al. 2002). Positive results 
including decreased metabolic cost, increased dorsiflexion during swing, and increased walking 
speed were observed in patients with MS wearing a low-stiffness, semi-active AFO (Bregman et 
al. 2010). However, these positive results were only observed in a subset of their population 
that did not attain neutral ankle angle during swing. The population that did not benefit from 
the AFO were less impaired.  A similar energy storing AFO with a spring-like behavior to assist 
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with ankle push-off was able to decrease metabolic cost by 9.8% and increase the peak 
plantarflexor torque in patients with MS (Bregman et al. 2012). Work at the ankle also 
decreased with the AFO, but a shift towards more work produced at the hip was observed. In 
contrast, no positive results in a functional gait test (i.e., timed 25 foot walk) with the use of 
AFOs in people with MS have also been found (Sheffler et al. 2008). In sum, the results have 
been mixed and limited to specific conditions or populations for prescribed AFOs in mitigating 
gait impairment of MS. 
 
Powered orthotic devices have been developed, enabling active motion control during the gait 
cycle. These powered orthoses have been designed to actuate the knee (Nikitczuk et al. 2007), 
ankle (Blaya and Herr 2004; Ferris et al. 2005; Ferris et al. 2006; Roy et al. 2009; Shorter et al. 
2011a; Mooney et al. 2014; Neubauer et al. 2014), or both the knee and ankle at the same time 
(Sawicki and Ferris 2009). Devices for the ankle are capable of increasing plantarflexor torque 
(Ferris et al. 2005), and decrease the metabolic cost of walking (Mooney et al. 2014) in healthy 
individuals. For people with gait impairment, devices for the ankle have been developed to 
prevent foot slap (Blaya and Herr 2004) and improve movement capabilities of patients post-
stroke (Roy et al. 2009; Takahashi et al. 2015). For example, a powered ankle foot orthosis that 
provided plantarflexion assistance was able to increase plantarflexor torque in people post-
stroke (Takahashi et al. 2015). Other robotic gait rehabilitation devices (i.e., robotic treadmill 
training) in which the person is driven through the walking motion by a robotic device can also 
be effective in improving gait speed in people with MS (Beer et al. 2008; Lo and Triche 2008), 
especially in the later stages of disease progression. However, no studies have directly 
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investigated the use of powered ankle-foot orthoses in people with MS. Therefore, devices that 
provide powered assistance to joints of the lower limbs during the gait cycle may be a 
promising new option for mitigation and rehabilitation of gait impairments of people with MS.  
 
A portable powered ankle-foot orthosis (PPAFO, Figure 2) testbed has been developed to 
investigate applications of powered ankle assistance during gait (Li et al. 2011; Shorter et al. 
2011a). On board electronics can be programmed to provide actuation during the gait cycle (Li 
et al. 2011; Islam et al. 2016; Islam and Hsiao Wecksler 2016) and changing environments (e.g. 
walking up/down stairs or slopes (Li and Hsiao-Wecksler 2013)). The PPAFO has been applied in 
populations such as mild spinal cord injury due to cauda equina syndrome (Shorter et al. 2011a) 
and MS (Boes et al. 2015). The PPAFO increased the propulsive vertical ground reaction forces 
in a single patient with cauda equina syndrome who was unable to properly generate 
plantarflexor torque at the ankle (Shorter et al. 2011a). In a small population (n = 16) of people 
with MS, use of the PPAFO decreased stride length, stride velocity, and 6-minute walk distance 
compared to the patient’s prescribed AFO in a moderate MS severity group (Boes et al. 2015). 
 
The research objective of this study was to compare the changes in gait kinematics and kinetics 
induced by a prescribed passive AFO and a powered ankle-foot orthosis in people with MS. We 
hypothesized that due to the added plantarflexor torque assistance of the powered ankle-foot 
orthosis, peak vertical and anterior-posterior propulsive forces, ankle torque, and plantarflexion 
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angle during terminal stance/pre-swing could be increased with the PPAFO compared to the 
prescribed AFO or when walking with only shoes.  
 
2.3 Methods 
2.3.1 Participants 
Sixteen participants (12 female, 4 male, age: 54.6 ± 5.3 yrs, weight: 83.4 ± 27.4 kg, height: 170.0 
± 8.5 cm, Expanded Disability Status Scale (EDSS): 5.1 ± 1.1, Table 1) with diagnosed MS 
participated in a larger protocol focused on testing the efficacy of the PPAFO for gait assistance 
(i.e., metabolic cost, spatiotemporal gait measurements) (Boes et al. 2015). For the current 
study, only five of the sixteen participants were analyzed due to reasons outlined in section 
2.3.6. Each participant wore a clinician-prescribed AFO for gait assistance on their more 
impaired limb. One participant wore a passive orthosis on their more impaired limb for all 
conditions. The study protocol was approved by the Institutional Review Board of the University 
of Illinois at Urbana-Champaign. All participants signed informed consent forms prior to 
participation in the study. 
  
2.3.2 Portable Powered Ankle Foot Orthosis 
The portable powered ankle foot orthosis (Figure 2) consisted of a custom set of carbon fiber 
shells for the shank (small, medium and large adult male) and foot pieces (able to 
accommodate US men’s sizes 4 to 14) joined through a bi-directional rotary pneumatic actuator 
(PRN30D-90-45, Parker Hannifin, Cleveland, OH, USA) aligned with the ankle joint axis. An 
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adjustable pressure regulator for the dorsiflexor torque was included in the device. The system 
utilized a microcontroller (MSP430G2553, Texas Instruments, Dallas, TX, USA) to control two 
solenoid valves (VUVG 5V, Festo Corp-US, Hauppauge, NY, USA) that modulated the flow of 
compressed CO2 to the two chambers of the actuator. The source of compressed CO2 was a 
tank (JacPac J-6901-91, 20 oz capacity, Pipeline Inc., Waterloo, ON, Canada). The tank was held 
by one of the researchers. Force resistive sensors (30-73258, Interlink Electronics Inc., Westlake 
Village, CA, USA) underneath the heel and toe region of the foot piece detected contact with 
the ground. A Hall-effect sensor (KMA199E, NXP Semiconductors Netherlands B.V., Eindhoven, 
Netherlands) was utilized to detect ankle angle. Readings from the three sensors informed the 
microcontroller of the current gait cycle state (0-100% gait cycle (GC)) of the user (Islam et al. 
2016). All sensors were sampled at 120 Hz.  
 
2.3.3 Protocol for PPAFO Training and 6-Minute Walk Tests 
The controller for the PPAFO was adjusted through a short training period (>10 minutes). First, 
the dorsiflexion regulator was heuristically adjusted to hold the participant’s toes in the neutral 
position (~3 Nm at 30 psig). Plantarflexor torque assistance was set to ~10 Nm at a pressure of 
100 psig. Initially, the controller provided assistance based on the gait events detected by the 
heel and toe sensors on the PPAFO (using a Direct Event controller, (Shorter et al. 2011a)). The 
participants were asked to walk for a minimum of 10 continuous steps while data were 
collected from the on-board heel, toe, and angle sensors. Then a custom minimization 
algorithm (MATLAB, Math Works Inc., Natick, MA) used the heel, toe, and angle sensor signals 
to train a Modified Fractional Time controller (Islam et al. 2016). Dorsiflexor and plantarflexor 
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torque actuation timings were based on normative ankle joint torque behavior during the gait 
cycle (Figure 3) (Perry 1992). The participant was then asked to walk with the newly adjusted 
Modified Fractional Time controller and the previous minimization algorithm was run again. 
This procedure was repeated at least three times. After completing the training protocol, 
participants were instructed to walk with the participant-specific controller in multiple hallways 
until they felt comfortable.  
 
As part of the larger protocol, 6MW tests were performed in three footwear conditions. The 
footwear conditions were wearing (1) their own walking shoes without an AFO [SHOES], (2) 
their prescribed AFO worn on their more impaired limb [AFO], (3) and the PPAFO worn on their 
more impaired limb [PPAFO]. For conditions 2 and 3, participants wore their normal walking 
shoe, except for the one participant who wore another passive AFO on the opposite leg for all 
conditions. The 6MWs were performed in counterbalance order with the SHOES condition 
always performed first and at least ten minutes of rest was provided between conditions.  
 
2.3.4 Protocol for Current Study 
After completing the last 6MW, participants had a ten minute rest period before performing at 
least three trials per footwear condition over a set of three force plates embedded in a slightly 
elevated walkway (Figure 4). Participants were asked to walk at a comfortable walking pace on 
the walkway; first in one direction and then next trial was collected walking in the opposite 
direction. Kinematic data from reflective markers placed on anatomical landmarks of the lower 
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limbs were recorded (8-camera Oqus 100 system, Qualisys AB, Gothenburg, Sweden). A 23 
marker set was used with reflective markers over the sacrum and ASIS, greater trochanter, 
thigh, lateral knee epicondyle, medial knee epicondyle, tibia, lateral malleolus, medial 
malleolus, fifth metatarsal head, and first metatarsal head of both legs. Ground reaction force 
data were recorded from three force plates (BP600900 and BP400600, Advanced Mechanical 
Technology Inc., Watertown, MA, USA) at 1000 Hz. Motion and ground reaction force data 
were filtered using 4th-order Butterworth low-pass filters (cutoff frequencies: 12 Hz for motion, 
75 Hz for force data). A “clean” trial was considered as a clean heel strike and stance phase over 
one or two of the force plates without the contralateral limb contacting the same plate(s). Any 
trial that was not considered “clean” was discarded. The order of conditions was 
counterbalanced in the reverse order of the 6MW. 
 
2.3.5 Data Analysis 
Kinematic and kinetic measurements (i.e., joint angles, torques, and ground reaction forces) 
were calculated using Visual 3D v5 (C-motion Inc., Germantown, MD, USA). The built-in heel 
strike recognition algorithm within Visual 3D was utilized to identify heel strikes and data were 
verified by visual inspection. Data were exported to MATLAB and normalized to the gait cycle 
(0-100% GC) between heel strikes. Ground reaction forces were normalized by the participant’s 
body weight, and torques were normalized by body weight and leg length of the more impaired 
limb. 
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Relevant peak behaviors and their timings (as %GC) during multiple phases of the gait cycle 
were analyzed for the impaired limb (Figure 5). Parameter selection was determined by 
previous analyses in people with MS (Benedetti et al. 1999; Kelleher et al. 2010). Peak 
parameters were analyzed from ground reaction forces (GRFs) in the anterior-posterior and 
vertical directions during the loading response (AP-GRFpk1, V-GRFpk1) and terminal stance (AP-
GRFpk2, V-GRFpk2). These parameters indicate the braking and propulsive force capabilities, 
which are known to be diminished in people with MS (Benedetti et al. 1999; Kelleher et al. 
2010). Additionally, the mid-stance minima in the vertical GRFs (V-GRFmin1) was analyzed 
because it has been shown to be significantly larger in people with MS (Benedetti et al. 1999). 
Three peak parameters were picked in the medial-lateral direction (Benedetti et al. 1999): 
during loading response (ML-GRFpk1), mid-stance (ML-GRFpk2) and terminal stance (ML-GRFpk3). 
Six ankle angle parameters were also analyzed to assess the overall ankle angle behavior during 
the gait cycle (Benedetti et al. 1999): at heel strike (θAnk1), maximum plantarflexion during 
stance (θAnk2), maximum dorsiflexion during stance (θAnk3), angle at toe-off (θAnk4), maximum 
plantarflexion during swing (θAnk5), and maximum dorsiflexion swing (θAnk6). Also, three ankle 
torque parameters during the gait cycle were analyzed: at heel strike torque (TAnk1), max 
dorsiflexor torque (TAnk2), and max plantarflexor torque (TAnk3). Peak plantarflexor torque has 
been demonstrated to be diminished in people with MS (Kelleher et al. 2010). Finally, gait 
speed (GS) was calculated for the stride over the force plates (stride length/stride time) by 
using the foot center of mass position at consecutive ipsilateral heel strikes. The average value 
of all trials within a condition for each subject was analyzed. In some instances, only one data 
point was available for a participant in a given condition. 
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2.3.6 Reasons for Participant Exclusion in Current Analysis 
The sample size for the current study was reduced from the total of 16 for various reasons 
(Table 1). Eight required the assistance of a walking aid (four used wheeled walkers, four used a 
single point cane), which interfered with the ground reaction force measurements when they 
walked over the force plate. The remaining eight participants did not require a walking aid. One 
participant did not complete the protocol because of data collection equipment malfunction 
the day of testing and was not rescheduled. Two of them did not have at least one “clean” trial 
in a footwear condition. Therefore, the data presented in this study were from the remaining 
five participants (three female, two male, age: 56.6 ± 3.5 yrs, weight: 79.9 ± 15.2 kg, height: 
172.7 ± 8.4 cm, EDSS: 4.0 ± 0.1, Table 1). This group was considered to have moderate MS 
impairment (EDSS ≤ 5.5).  
 
2.3.7 Statistical Analysis 
A series of repeated measures MANOVAs were run to assess the effect of footwear condition 
on kinetic and kinematic data (SPSS v22, IBM Corporation, Armonk, New York). First, a 
MANOVA including all 16 sagittal plane kinetic parameters (AP-GRF, V-GRF, ankle torque) and 
gait speed was run. ML-GRF parameters were not included in any statistical analyses due to a 
high amount of variability in these data (Figure 7, Table 2). Eleven ankle kinematic angle 
parameters were analyzed in a second MANOVA with a reduced sample size (n = 3) due to drop 
out of shank segment markers of two participants (Table 1). Follow up univariate ANOVAs were 
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performed for relevant parameters. Significance level was set at α = 0.05. Post-hoc comparisons 
were made between conditions using Tukey’s Honestly Significant Difference Test (HSD).  
 
2.4 Results 
Several significant differences in kinetic parameters were found while none were observed in 
the ankle angle parameters (Figure 6, Figure 7, Table 2, and Table 3). A significant main effect of 
footwear was noted for the kinetic parameter MANOVA (p = 0.001). Follow up univariate 
ANOVAs indicated significant differences between footwear conditions for two ground reaction 
force magnitudes (V-GRFmin1 and V-GRFpk2) and the peak plantarflexor ankle torque (TAnk3). No 
significant difference between conditions was found for gait speed (p = 0.139, Table 2), but 
there was a trend that the PPAFO condition was slower compared to the SHOES (-8% change) 
and AFO (-8.1% change) conditions. There were no significant differences in ankle angle 
position parameters due to footwear condition (p = 0.217). 
 
Modest changes were observed in the general behavior of the ground reaction forces in the 
PPAFO condition (Figure 6, Figure 7, and Table 2). Two amplitude parameters (V-GRFmin1 and V-
GRFpk2) in the vertical ground reaction forces had significant changes due to footwear. The mid-
stance minima was significantly increased (V-GRFmin1, p = 0.048) in the PPAFO condition 
compared to the AFO condition (5.5% change). The change in timing of this minima was 
borderline significant (V-GRFtmin1, p = 0.050) with the PPAFO condition occurring earlier in the 
gait cycle compared to both the SHOES and AFO conditions. A significant change was observed 
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for the propulsive vertical ground reaction force (V-GRFpk2, p = 0.026). V-GRFpk2 was significantly 
greater in the PPAFO condition than the SHOES condition (3% change). The average timing of 
the propulsive ground reaction peak in the anterior-posterior direction (AP-GRFpk2, Figure 7) 
appeared to be earlier in the PPAFO condition, but no significant differences between 
conditions were found (p = 0.489).  
 
The general behavior of the ankle torque was similar across conditions with one significant 
difference (Figure 6, Figure 7, and Table 2). A significant decrease in peak plantarflexor torque 
(TAnk3, p = 0.008) was observed in the PPAFO condition compared to the SHOES condition (-
16.8% change). Changes in peak dorsiflexor torque (TAnk2) were modestly larger in the AFO 
condition compared to the SHOES and PPAFO conditions, but not statistically significant (p = 
0.114). 
 
2.5 Discussion 
The objective of this study was to evaluate the changes in gait kinetics and kinematics in people 
with MS associated with the implementation of a powered ankle-foot orthosis compared to 
walking in a prescribed AFO or shoes. We hypothesized that peak vertical and anterior-
posterior propulsive forces, plantarflexor ankle torque, and plantarflexion angle during terminal 
stance/pre-swing could be increased with the PPAFO compared to passive AFOs or walking 
shoes. Overall, the results of this study demonstrate that using the PPAFO for gait assistance 
can result in changes from baseline walking in shoes. However, two of the three significant 
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changes associated with the PPAFO were not different from the AFO condition, indicating that 
the two devices did not greatly differ in modulating gait kinetics. Finally, no significant 
differences were found in the ankle angle parameters, probably due to the low sample size for 
those data (n = 3). Results of this study suggests that the PPAFO may be able to modulate the 
kinetics of gait in people with MS.  
 
Application of a powered ankle-foot orthosis in people with MS induced modest changes in 
vertical ground reaction forces towards normative behaviors. Typically, people with lower levels 
of MS disability have decreased propulsive and breaking forces as well as vertical ground 
reaction force peaks (Benedetti et al. 1999; Kelleher et al. 2010). The PPAFO increased the 
vertical propulsive force (V-GRFpk2) compared to baseline walking in shoes, suggesting a 
possible restoration of normal behavior (Figure 6, Figure 7, Table 2). This change is consistent 
with previous use of the PPAFO in a person with cauda equina syndrome who was unable to 
sufficiently generate plantarflexor torque (Shorter et al. 2011a). However, there was no 
concomitant increase in the propulsive anterior-posterior ground reaction forces in the current 
study (Figure 7, Table 2), which are also decreased in people with MS (Benedetti et al. 1999; 
Kelleher et al. 2010). A similar lack of increased anterior-posterior force with applied 
plantarflexor torque on the impaired limb of patients post-stroke has been observed (Takahashi 
et al. 2015). The reason for the lack of increased anterior-posterior force in these scenarios is 
unclear. Further investigation into the changes in ground reaction forces associated with 
increased plantarflexor torque from an external device is needed. 
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The only difference between the AFO and PPAFO conditions was the mid-stance minima in the 
vertical ground reaction forces was greater in the PPAFO condition (vGRFmin1, Figure 6, Figure 7, 
Table 2). This increase is a possible indication of slower gait speed (Neptune and Sasaki 2005). 
Although it was not a statistically significant change, participants walked slower with the PPAFO 
compared to SHOES and AFO in the current study. During the longer six-minute walk test 
(6MW) portion of the larger study, stride velocity in the PPAFO condition was found to be 
significantly slower than the SHOES and AFO conditions (Boes et al. 2015).  
 
Interestingly, with an increase in vertical propulsive force, a concomitant increase in peak 
plantarflexor torque (TAnk3) was not observed with the PPAFO. Instead, the peak plantarflexor 
torque was significantly smaller in the PPAFO condition compared to the SHOES condition 
(Figure 6, Figure 7, and Table 2). This change in plantarflexor torque could simply be due to 
slower walking speed in the PPAFO condition. Previous studies have shown that elderly adults 
have decreased plantarflexor torque at slower gait speeds (Kerrigan et al. 1998; DeVita and 
Hortobagyi 2000). The PPAFO was expected to be providing 10 Nm of torque during terminal 
stance/pre swing when peak plantarflexor torque should be achieved. Given the lack of 
increased plantarflexor torque, the participants could have re-optimized their contribution of 
plantarflexor torque while wearing the PPAFO. Similar adaptations to a powered ankle foot 
orthosis were observed in people post-stroke (Takahashi et al. 2015). In that study, the overall 
peak plantarflexor torque (i.e., the user’s contribution plus the device) was increased with the 
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powered ankle-foot orthosis compared to baseline walking without the device. Further, gait 
speed was constrained in that study across conditions because the data were collected on a 
treadmill. Thus, it is possible that if gait speed was constrained in our study (e.g., with a 
treadmill), then the plantarflexor torque might have also increased with the PPAFO in our 
participants as well. 
 
Different aspects of the form and function of the PPAFO have to be considered to improve the 
efficacy of the device. The current controller is based on “on-off” timings and the actuation is 
either all on or all off (i.e., “bang-bang” control). The nature of this actuation scheme makes it 
difficult to ramp of the ankle torque as it naturally does in the human body. Furthermore, if the 
actuation is turned on too early or late, it could potentially inhibit the desired torque output at 
the ankle. Future investigations should consider testing different torque and timing sequence 
and its effect on the kinematics and kinetics of gait (Islam and Hsiao Wecksler 2016). From the 
device design perspective, actuation systems that utilize proportional control of the actuator 
could enable a more natural ankle torque profile.  Additionally, general factors such as 
improving the fit and reducing the weight of the device could improve the function of the 
PPAFO (Barnett et al. 1993). 
 
Although significant effects were found, the results of this study should be interpreted knowing 
there were a few limitations. First, the reduced sample size makes it difficult to draw any 
conclusions of how the device could modulate gait kinetics in all people with MS. For example, 
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the participants in this study were limited to moderate levels of MS, so very little can be 
interpreted about gait kinetics for people with severe levels of MS. Robotic treadmill training 
was able to improve gait speed in people with severe levels of MS (EDSS ≥ 6.0) (Beer et al. 2008; 
Lo and Triche 2008), so it is conceivable that a powered ankle foot orthosis that also provides 
physical assistance during the gait cycle could be beneficial for these individuals. However, it is 
also possible that a null result could be observed. Results from participants with severe MS 
(EDSS ≥ 6.0) had less of a change in gait speed and metabolic cost of walking with the PPAFO 
compared to the other conditions in the 6MWs of this study (Boes et al. 2015). Something else 
to consider is we do not know if there were even greater benefits to wearing the PPAFO over 
the course of multiple days or longer training sessions. In this study, the controller was trained 
while the participants first wore the device for 3 periods of ~10 steps each. During this time, the 
participants may have still been getting used to the device, so the controller could have been 
tuned to them walking with a slower, more conservative gait. With more training, the 
participants could have become more comfortable with the device and would not have had to 
resort to a conservative gait strategy. Future kinetic studies should focus on an increased 
sample size across multiple levels of MS disability with additional training. 
 
2.6 Conclusions 
Results of this study suggest that positive changes in kinematics and kinetics of gait can be 
induced by a powered ankle-foot orthosis in people with moderate of MS severity. Further 
investigation is needed into properly timing and magnitude of assistance to improve the 
efficacy of the PPAFO in modulating gait impairments of people with MS. 
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Figure 2: The portable powered ankle-foot orthosis (PPAFO). Photo is courtesy of Professor Cliff Shin in 
the Department of Industrial Design at the University of Illinois at Urbana-Champaign.
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Figure 3: PPAFO actuation timings and magnitudes during the gait cycle (Perry 1992).
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Figure 4: Data collection configuration of force plates with in the elevated walkway. The motion capture 
space is outlined in the blue dotted line. 
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Figure 5: Data analysis parameters for ground reaction forces, ankle angle, and ankle torque. The 
vertical dashed line in each plot indicates the time of toe-off. 
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Figure 6: Average ground reaction force and torque parameters (± SEM) where significant differences 
were found between footwear conditions. The horizontal bar indicates a significant difference between 
conditions (p < 0.05). 
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Figure 7: Average behaviors of ground reaction forces and ankle torque across conditions. The data are 
displayed as average ± standard deviation in the right panels.
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Table 1: Demographics of all participants with reasons for exclusion from the overall analysis (assistive device required or no "clean" heel strikes) 
or ankle angle analysis (did not have a trial with all ankle angle parameters) highlighted. 
 
ID Walking Aid Age Gender Weight (kg) Height (cm) Shoe Size (US) AFO Leg EDSS 
001 Cane 45 F 60.6 163.4 W9.5 L 6 
002 Cane 44 F 69.2 167.0 W8 R 6 
003 None 51 F 117.4 171.7 W9 R 4.5 
004 Walker 58 F 65.8 151.4 W6 R 6 
005 AFO kept on left leg throughout 56 M 81.0 180.0 M9 R 3.5 
006 Cane 53 F 45.5 166.8 W9 L 6.5 
007 Walker 55 F 139.6 172.9 W11 R 6 
009 Walker 62 M 109.6 172.4 M10.5 L 6.0 
010 Walker 60 F 116.2 174.0 M10.5 R 6.5 
011 None 59 F 68.6 170.7 W9.5 L 3.5 
012 None 57 F 65.0 160.9 W8.5 L 4 
013 None 51 F 65.7 176.2 W9 L 4 
015 Cane 51 M 96.1 185.6 M11.5 L 6 
016 None 53 F 47.0 160.4 W7 R 5.5 
018 None 59 F 86.4 167.0 W8 L 4 
019 None 60 M 101.4 179.3 M12 R 4 
         
         
  Did not collect ground reaction force data 
  Assistive device needed 
 Did not have at least 1 "clean" heel strike trial in one (or more) conditions 
  Did not have at least 1 trial with all ankle angle parameters in one (or more) conditions 
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Table 2: Average ground reaction force, ankle torque, and gait speed parameters across footwear 
conditions (± SD) with p-values from the univariate ANOVAs. Significant p-values are in bold (p < 0.05).  
Anterior-Posterior GRF 
  Shoes AFO PPAFO p-value 
AP-GRFpk1 (N/Kg) -1.27 ± 0.36 -1.12 ± 0.35 -1.40 ± 0.34 0.186 
AP-GRFtpk1 (% GC) 10.2 ± 2.8 13.5 ± 1.5 11.2 ± 2.6 0.113 
AP-GRFpk2 (N/Kg) 0.97 ± 0.13 0.97 ± 0.18 0.87 ± 0.21 0.437 
AP-GRFtpk2 (% GC) 50.8 ± 7.0 49.0 ± 6.1 47.4 ± 4.2 0.489 
Medial-Lateral GRF 
  Shoes AFO PPAFO p-value 
ML-GRFpk1 (N/Kg) -0.19 ± 0.12 -0.32 ± 0.14 -0.18 ± 0.09 - 
ML-GRFtpk2 (% GC) 4.6 ± 2.3 3.8 ± 1.7 3.2 ± 2.1 - 
ML-GRFpk2 (N/Kg) 0.80 ± 0.32 0.78 ± 0.13 0.83 ± 0.29 - 
ML-GRFtpk2 (% GC) 19.1 ± 2.5 21.8 ± 2.8 19.3 ± 6.9 - 
ML-GRFpk3 (N/Kg) 0.69 ± 0.36 0.66 ± 0.19 0.687 ± 0.28 - 
ML-GRFtpk3 (% GC) 41.9 ± 4.4 43.5 ± 6.9 38.8 ± 8.8 - 
Vertical GRF 
  Shoes AFO PPAFO p-value 
V-GRFpk1(N/Kg) 10.21 ± 0.66 10.55 ± 0.66 10.35 ± 0.55 0.264 
V-GRFtpk1 (% GC) 18.9 ± 2.7 19.2 ± 2.3 18.1 ± 3.0 0.804 
V-GRFmin1  (N/Kg) 7.94 ± 0.61 7.82 ± 0.51 8.26 ± 0.64 0.048 
V-GRFtmin1 (% GC) 32.2 ± 3.8 32.6 ± 2.3 27.8 ± 4.4 0.050 
V-GRFpk2 (N/Kg) 9.46 ± 0.15 9.61 ± 0.25 9.75 ± 0.26 0.026 
V-GRFtpk2 (% GC) 43.4 ± 4.6 44.2 ± 4.7 40.8 ± 4.4 0.319 
Ankle Torque 
  Shoes AFO PPAFO p-value 
TAnk1 (N-m/kg-m) 0.00 ± 0.03 -0.03 ± 0.05 -0.03 ± 0.06 0.229 
TAnk2 (N-m/kg-m) -0.08 ± 0.07 -0.20 ± 0.19 -0.12 ± 0.06 0.114 
TtAnk2 (% GC) 3.3 ± 1.3 5.8 ± 2.4 5.8 ± 3.1 0.195 
TAnk3 (N-m/kg-m) 1.30 ± 0.26 1.22 ± 0.23 1.08 ± 0.17 0.008 
TtAnk3 (% GC) 48.2 ± 2.6 49.1 ± 2.5 46.9 ± 2.8 0.368 
Gait Speed 
  Shoes AFO PPAFO p-value 
GS (m/s) 0.98 ± 0.11 0.98 ± 0.07 0.90 ± 0.08 0.139 
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Table 3: Average ankle angle of 3 participants that did not have missing motion data across footwear 
conditions (+/- SD). No main effect of the MANOVA for these parameters was found, so no univariate p-
values are provided. 
Ankle Angle (3 Participants) 
  Shoes AFO PPAFO 
θAnk1 (°) -4.1 ± 4.4 -3.2 ± 3.0 -3.4 ± 1.4 
θAnk2 (°) -11.3 ± 4.0 -8.6 ± 4.4 -9.7 ± 6.3 
θtAnk2 (% GC) 5.6 ± 0.4 5.3 ± 1.2 5.0 ± 2.0 
θAnk3 (°) 13.4 ± 0.7 12.0 ± 2.5 8.4 ± 3.7 
θtAnk3 (% GC) 51.8 ± 1.3 51.3 ± 1.6 50.3 ± 1.2 
θAnk4 (°) -8.6 ± 5.6 -4.1 ± 4.8 -6.1 ± 2.8 
θtAnk4 (% GC) 64.7 ± 2.7 63.9 ± 2.5 63.8 ± 0.7 
θAnk5 (°) -11.6 ± 7.0 -6.3 ± 5.8 -7.3 ± 3.4 
θtAnk5 (% GC) 66.8 ± 2.4 66.0 ± 2.0 65.1 ± 1.3 
θAnk6 (°) -0.2 ± 5.3 0.6 ± 4.3 3.3 ± 1.4 
θtAnk6 (% GC) 85.4 ± 5.1 85.4 ± 7.6 86.8 ± 5.6 
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3 Conclusions and Future Work 
In this thesis, we utilized the PPAFO to investigate the effectiveness of a powered ankle-foot 
orthoses for changing the kinematic and kinetics of gait compared to standard AFOs in people 
with MS. We hypothesized that due to active motion control in both dorsiflexion and 
plantarflexion that propulsive forces and torque would be increased compared to a standard 
prescribed orthoses or normal walking shoes. Significant increases in the vertical ground 
reaction force magnitude at mid-stance (compared to the AFO condition) and during terminal 
stance (compared to the SHOES condition) were observed in the PPAFO condition (Figure 6, 
Table 2). However the propulsive vertical ground reaction force was not significantly increased 
when compared to the AFO condition (Figure 7, Table 2). Furthermore, the peak plantarflexor 
torque was significantly reduced in the PPAFO condition compared to SHOES, but no 
differences existed between the PPAFO and AFO conditions (Figure 6, Table 2). These findings 
suggest that changes in gait kinetics are possible with the PPAFO. Additional investigation is 
needed to determine if improved gait kinematic and kinetics can be achieved with a powered 
ankle-foot orthosis compared to a prescribed AFO for people with MS.  
 
3.1 Future Work  
The main objective of using a powered ankle-foot orthosis, or any gait intervention, for people 
with MS will be keeping them ambulatory as long as possible during the disease course. Several 
key factors have to be investigated in order to achieve this goal with a powered ankle-foot 
orthosis. These include improved PPAFO control for providing assistance when it is needed 
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during the gait cycle, optimizing the training period needed with the PPAFO to induce the 
desired changes in gait characteristics, and applying the device in people with MS at multiple 
levels of MS severity.  
 
Optimization of the PPAFO controller is needed to induce the desired biomechanics and 
maximize the efficacy of the PPAFO in people with MS. In this study, the PPAFO was able to 
restore more normative propulsive vertical ground reaction forces. However, no change in the 
anterior-posterior propulsive force or ankle angle were observed. The decrease in plantarflexor 
torque may have been caused by the plantarflexor torque from the device being activated too 
soon during mid-stance. Machine learning techniques and control techniques are currently 
being utilized to address the problem of torque timing in our lab (Islam and Hsiao Wecksler 
2016) and further investigation is still needed. Moreover, the application of proportional torque 
control (i.e., tracking the torque output of the user and device), instead of the “bang-bang” 
kinematic control of our current controller, could be beneficial to mimic the natural torque 
generation at the ankle. If the controller is tuned to encourage more normative behaviors, 
improved gait kinematics, ground reaction forces, and ankle torque may be achieved in people 
with MS, which would could also result in faster gait speed.  
 
In addition to the actuation of the PPAFO, the amount of training necessary for the PPAFO to 
have positive changes on the kinetics and kinematics of gait is still an open question. In this 
study, the minimization algorithm for the controller was run when the participants first wore 
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the device for 3 periods of ~10 steps each. During this time, the participants may have still been 
getting used to the device, so the controller may have been tuned to them walking with a 
slower, more conservative gait. Currently, it is not clear if extending this training period, or 
allowing the participants to retrain the device after familiarization (i.e., on the same day, or 
over the course of multiple days), would have resulted in improved biomechanics with the 
PPAFO. Optimizing the training period along with PPAFO actuation could result in an even larger 
benefit for the PPAFO. 
  
Finally, it is unclear if similar changes in kinematics and kinetics would be observed in people 
with severe levels of MS impairment (EDSS ≥ 6.0). Previous robotic body weight support 
treadmill training would suggest that robotic assistance could have a positive effect on people 
with higher levels of MS disease severity (Beer et al. 2008; Lo and Triche 2008). One thing to 
consider is people with higher levels of MS severity typically walk even slower than people with 
low levels of MS disease severity (Kelleher et al. 2010). Thus, if the reduced peak plantarflexor 
torque and a lack of peak sagittal shear force during terminal stance observed in this study 
were because of slower gait speed, the same type of results may be expected in people with 
higher MS disability. At the same time, a null result could be observed. As part of this study, the 
results from the 6MWs of participants with higher MS impairment (EDSS ≥ 6.0) suggest there 
was no change in gait speed or metabolic cost of walking with the PPAFO compared to the AFO 
and SHOES conditions (Boes et al. 2015). Further investigation is needed, but if the PPAFO is 
properly tuned to encourage more normative biomechanics, it could promote independence 
and increase mobility for people with severe levels of MS impairment.   
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Appendix A: Additional Ankle Angle Data 
Two of the participants in this study were excluded from the ankle angle analysis because 
marker drop out in the shank segment (Table 1). The purpose of this Appendix is to provide the 
ankle angle data across all participants for reference. Note, in each participant figure, the 
separate colors delineate separate trials for that condition. Additionally, averages across all five 
participants and the three included in the statistical analysis are provided (Figure 13). 
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Figure 8: All ankle angle trials by condition for participant 005. Note, even though there are data missing 
in the middle of the PPAFO trial, all of the parameters were able to be identified. 
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Figure 9: All ankle angle trials by condition for participant 012. Note there are not enough data in the 
AFO and PPAFO conditions to be able to identify every ankle angle parameter. Thus, this participant was 
not included in the statistical analysis. 
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Figure 10: All ankle angle trials by condition for participant 013. Note, although there is continuous data 
during swing of the PPAFO trial, it was determined that the small “jump” in the data around 86% gait 
cycle was caused by motion markers dropping in and out of the frame. Thus, we could not include the 
max dorsiflexion angle during swing in the statistical analysis. 
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Figure 11: All ankle angle trials by condition for participant 018. Note, there were more than three trials 
in the AFO condition. Only the first three were included in the analysis. 
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Figure 12: All ankle angle trials by condition for participant 018. Note, there were more than three trials 
in the SHOES and AFO conditions. Only the first three were included in the analysis. 
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Figure 13: Average ankle angle behaviors across footwear conditions for all five participants (top) and 
the three participants (bottom) that did not have parameters lost due to marker dropout. Data are 
displayed as the average ± SD. 
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Appendix B: Analysis of Changing PPAFO Weight on Ankle Torque 
In this study, the weight of the PPAFO was not included in the inverse dynamics calculations for 
ankle torque. To evaluate how much the added weight would affect the calculation of ankle 
torque, an increased weight of 0.2 kg was added to the model of the foot and the ankle torque 
was recalculated. Results demonstrate that if only the actuator was considered (0.474 kg), the 
difference in peak plantarflexor torque would have been between -0.008 and -0.012 (N-m/kg-
m) (Table 5). It would be a safe assumption to consider the actuator weight alone because the 
foot shell is a similar weight to a standard walking shoe, and the shank shell and valves are not 
attached to the foot of the user. In the worst case, if the full weight of the PPAFO would have 
been included (1.176 kg, Table 4), a decrease in peak plantarflexor torque would be observed 
(between -0.018 to -0.022 (N-m/kg-m), Table 5). Ultimately, these difference in peak 
plantarflexor torque are minimal in comparison to the average ankle torque values in this study 
(1.08-1.30 (N-m/kg-m)). Furthermore, the significant decrease in peak plantarflexor torque in 
the PPAFO condition would have still been observed with these changes in foot weight. 
Table 4: Weight of each component of the PPAFO. 
Item Weight 
Actuator 0.474 kg 
Foot Shell 0.410 kg 
Shank Shell 0.246 kg 
Valves 0.046 kg 
Total 1.176 kg 
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Table 5: Differences in peak plantarflexor torque at specific increments of additional foot weight. 
Additional Foot Weight Difference at Peak Plantarflexor Torque 
0.2 kg -0.004 (N-m)/(kg-m) 
0.4 kg -0.008 (N-m)/(kg-m) 
0.6 kg -0.012 (N-m)/(kg-m) 
0.8 kg -0.016 (N-m)/(kg-m) 
1.0 kg -0.018 (N-m)/(kg-m) 
1.2 kg -0.022 (N-m)/(kg-m) 
 
